Takeda Pharmaceuticals: Global Homepage About Our Company Leadership Corporate Responsibility Corporate Sustainability Sustainability Approach Access to Medicines Sustainability Disclosures Ethics & Disclosures Ethics Transparency Disclosures Positions Corporate Giving Corporate Governance Governance Strategy Governance Structure Charters and Reports Science Areas of Focus Research and Development Pipeline Products Our Products Manufacturing Suppliers Clinical Trials Our Stories Newsroom Press Releases Statements Media Resources Investors Overview Financial Results Investor Events Investor Contact Careers ABOUT Our Company Leadership Corporate Responsibility Chevron right Corporate Sustainability Chevron right Sustainability Approach Access to Medicines Sustainability Disclosures Ethics & Disclosures Chevron right Ethics Transparency Disclosures Positions Corporate Giving Corporate Governance Chevron right Governance Strategy Governance Structure Charters and Reports SCIENCE Areas of Focus Research and Development Pipeline Products Chevron right Our Products Manufacturing Suppliers Clinical Trials OUR STORIES NEWSROOM Press Releases Statements Media Resources INVESTORS Overview Financial Results Investor Events Investor Contact CAREERS Open location finder Global Vertical line EN Close Takeda - Global English English Japanese Japanese Search Algeria English English French French Arabic Arabic Argentina Spanish Spanish Australia English English Austria German German Belarus Russian Russian Belgium English English French French Dutch Dutch Bosnia and Herzegovina Bosnian Bosnian Brazil Portuguese Portuguese Bulgaria Bulgarian Bulgarian Canada English English French French Chile Spanish Spanish Mainland China Chinese Chinese Colombia Spanish Spanish Croatia Croatian Croatian Czech Republic Czech Czech Denmark Danish Danish Ecuador Spanish Spanish Egypt English English Arabic Arabic Estonia Estonian Estonian Finland Finnish Finnish France French French Germany German German Greece Greek Greek Hong Kong SAR English English Chinese Chinese Hungary Hungarian Hungarian India English English Indonesia Indonesian Indonesian Ireland English English Israel Hebrew Hebrew Italy Italian Italian Kazakhstan Kazakh Kazakh Russian Russian Korea Korean Korean Latvia Latvian Latvian Lithuania Lithuanian Lithuanian Malaysia English English Mexico Spanish Spanish Netherlands Dutch Dutch New Zealand English English Norway Norweigan Norweigan Peru Spanish Spanish Philippines English English Poland Polish Polish Portugal Portuguese Portuguese Romania Romanian Romanian Russia Russian Russian Saudi Arabia English English Arabic Arabic Serbia Serbian Serbian Singapore English English Slovakia Slovak Slovak Slovenia Slovenian Slovenian South Africa English English Spain Spanish Spanish Sweden Swedish Swedish Switzerland German German French French Taiwan Chinese Chinese Thailand Thai Thai Turkey Turkish Turkish Ukraine Ukrainian Ukrainian United Arab Emirates English English Arabic Arabic United Kingdom English English United States English English Vietnam English English Takeda Pharmaceuticals: Global Homepage Bridging to The Future: Our Leaders Shaping a Bold New Chapter ## Bridging to The Future: Our Leaders Shaping a Bold New Chapter Learn More Recent News <h2 style="text-align: center;">Recent News</h2> Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment Calendar December 18, 2025 Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera Calendar December 6, 2025 Takeda Announces Closing of Strategic Partnership with Innovent Biologics for Next-Generation Investigational Oncology Medicines Takeda Announces Closing of Strategic Partnership with Innovent Biologics for Next-Generation Investigational Oncology Medicines Calendar December 4, 2025 Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy Calendar November 7, 2025 View All We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives. Better Health, Brighter Future ## Better Health, Brighter Future Join Us ### Join Us Work with globally diverse colleagues who are committed to bringing Better Health to people and a Brighter Future to the world. Work with globally diverse colleagues who are committed to bringing Better Health to people and a Brighter Future to the world. FIND OUT MORE **FIND OUT MORE** Investors ### Investors Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth. Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth. FIND OUT MORE **FIND OUT MORE** R&D ### R\&D Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines. Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines. FIND OUT MORE **FIND OUT MORE** Our Areas of Focus ## Our Areas of Focus Gastrointestinal and Inflammation ### Gastrointestinal and Inflammation Understanding and addressing life-limiting gastrointestinal and inflammatory diseases Understanding and addressing life-limiting gastrointestinal and inflammatory diseases Go to  Gastrointestinal and Inflammation page Rare Diseases ### Rare Diseases Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders Go to  Rare Diseases page Plasma-Derived Therapies ### Plasma-Derived Therapies Improving the lives of patients with rare and complex chronic diseases through innovation in plasma Improving the lives of patients with rare and complex chronic diseases through innovation in plasma Go to  Plasma-Derived Therapies page Oncology ### Oncology Aspiring to cure cancer, with inspiration from patients and innovation from everywhere Aspiring to cure cancer, with inspiration from patients and innovation from everywhere Go to  Oncology page Neuroscience ### Neuroscience Driving medical innovation for patients with neurological diseases Driving medical innovation for patients with neurological diseases Go to  Neuroscience page Vaccines ### Vaccines Addressing unmet global health needs through vaccine development against infectious diseases Addressing unmet global health needs through vaccine development against infectious diseases Go to  Vaccines page Sign up for investors newsletter ## Sign up for investors newsletter Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet Sign up LinkedIn YouTube Locations Contact us Careers Financial Highlights HCPs Patients This website provides information about Takeda's worldwide business. For specific information about our local markets, please use the country selector . This website provides information about Takeda's worldwide business. For specific information about our local markets, please use the [country selector](/worldwide). Terms and Conditions Privacy Notice Cookie Policy Accessibility Statement Copyright 1995-2025 Takeda Pharmaceutical Company Limited. All rights reserved. Copyright 1995-2025 Takeda Pharmaceutical Company Limited. All rights reserved.